The sleep apnea devices market size has grown strongly in recent years. It will grow from $7.94 billion in 2024 to $8.43 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to aging population, obesity epidemic, increased recognition of comorbidities, globalization of sleep apnea awareness, prevalence of sleep apnea.
The sleep apnea devices market size is expected to see strong growth in the next few years. It will grow to $11.72 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to advancements in home sleep testing, personalized treatment approaches, increasing adoption of oral appliances, focus on pediatric sleep apnea, patient compliance improvement, emerging markets and increased access. Major trends in the forecast period include telemedicine and remote monitoring, portable and travel-friendly devices, integration of wearable technologies, customization and personalization of therapies, research in implantable devices.
The anticipated growth in the sleep apnea devices market is fueled by the escalating prevalence of sleep apnea disorders. Characterized by recurrent pauses and starts in breathing during sleep, sleep apnea poses potential health risks, making sleep apnea devices crucial for treatment and prevention of sleep disturbances. These devices operate by continuously delivering pressurized air through tubing into a sleep mask, preventing the collapse of the patient's airways. Notably, in April 2022, the American Medical Association (AMA) reported that in the United States alone, 30 million people suffered from sleep apnea. The prevalence of sleep apnea affects one in fifteen Americans, constituting 6.62 percent of the population, with around 30 percent reporting symptoms. Consequently, the rising prevalence of sleep apnea disorders is a key driver for the growth of the sleep apnea device market.
The surge in obesity rates is expected to further propel the expansion of the sleep apnea devices market. Obesity, a medical condition characterized by the excessive accumulation of body fat, poses a significant health threat and is closely linked to sleep apnea. The global increase in obesity rates contributes to the heightened prevalence of sleep apnea, necessitating effective equipment for its management. In March 2022, the World Health Organization (WHO) reported that approximately 1 billion people worldwide, including 650 million adults, 340 million teenagers, and 39 million children, were classified as obese. This number continues to grow, with an estimated 167 million adults and children expected to face health consequences due to overweight or obesity by 2025. Consequently, the upward trend in obesity rates is a driving factor for the sleep apnea device market.
Key companies in the sleep apnea devices market are concentrating on developing innovative devices, such as bi-level positive airway pressure (BiPAP) machines, to enhance patient comfort and improve treatment adherence. BiPAP is a type of non-invasive ventilation primarily used to treat sleep apnea and other respiratory conditions. It provides two levels of pressure: a higher pressure during inhalation (IPAP) to help keep the airway open and a lower pressure during exhalation (EPAP) to facilitate easier breathing out. For example, in February 2024, ResMed, a U.S.-based medical device company, introduced the AirCurve 11 series. This new range of bilevel positive airway pressure (PAP) devices is designed to improve sleep apnea treatment by enhancing patient comfort and encouraging compliance with therapy.
Major players in the sleep apnea devices market are embracing a strategic partnership approach to facilitate home-based sleep apnea detection. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefit. For instance, in May 2023, Signifier Medical Technologies LLC, a US-based medical technology company, announced a partnership with Sunrise, a Hong Kong-based healthcare technology company. This collaboration integrates Sunrise's AI solutions with Signifier Medical's eXciteOSA daytime sleep apnea therapy technologies, enhancing patient care through more efficient diagnosis and treatments. The joint offering includes personalized home sleep testing and a patient management portal, empowering healthcare professionals to gather comprehensive information on patients' daily clinical experiences and optimize outcomes.
In July 2024, EnsoData, a U.S.-based software company, acquired sleep testing diagnostic technology from Resonea for an undisclosed sum. This acquisition is intended to significantly enhance EnsoData's capabilities in screening and diagnosing sleep apnea. The focus of this acquisition is to reduce costs and improve access to systematic screening for sleep apnea. Resonea is a company based in Arizona that specializes in sleep diagnostics.
Major companies operating in the sleep apnea devices market include ResMed Inc., Fisher And Paykel Healthcare Corporation Limited, Natus Medical Incorporated, Compumedics Limited, Somnoware Healthcare Systems Inc., DeVilbiss Healthcare LLC, Braebon Medical Corporation, Koninklijke Philips N.V., BMC Medical Co. Ltd., Lowenstein Medical Technology GmbH Co. KG, Nihon Kohden Corporation, Invacare Corporation, Cadwell Industries Inc., Oventus Medical Ltd., Inspire Medical Systems Inc., Itamar Medical Ltd., APEX Medical Corp., Drive DeVilbiss Healthcare, 3B Medical Inc., Airing LLC, Airway Management Inc., Bleep LLC, Circadiance LLC, GE Healthcare, HOFFRICHTER GmbH, Human Design Medical LLC, ImThera Medical Inc., Provent Sleep Therapy LLC, Resonea Inc., Sleepnet Corporation.
North America was the largest region in the sleep apnea devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global sleep apnea devices market during the forecast period. The regions covered in the sleep apnea devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sleep apnea devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Sleep apnea devices encompass a range of advanced equipment, notably Continuous Positive Airway Pressure (CPAP) machines, designed to mitigate snoring and prevent sleep apnea. These CPAP devices precisely administer optimal air pressure to a mask, ensuring the maintenance of open upper airway passages.
Key categories within the sleep apnea devices market include airway clearance systems, adaptive servo-ventilation (ASV), positive airway pressure (PAP) devices, oral appliances, oxygen devices, sleep screening devices, actuation systems, polysomnography (PSG) devices, and respiratory polygraphs. Airway-clearing systems, a vital component, aid in the expulsion of thick mucus, facilitating coughing or huffing to clear the lungs. This technology is instrumental in addressing conditions such as obstructive sleep apnea syndrome, central sleep apnea syndrome, and complex sleep apnea syndrome. Targeting diverse age demographics, including pediatric, adult, and geriatric populations, these devices find application across various healthcare settings, such as hospitals, clinics, diagnostic centers, ambulatory care centers, specialty care centers, and home healthcare.
The sleep apnea devices market research report is one of a series of new reports that provides sleep apnea devices market statistics, including sleep apnea devices industry global market size, regional shares, competitors with a sleep apnea devices market share, detailed sleep apnea devices market segments, market trends and opportunities, and any further data you may need to thrive in the sleep apnea devices industry. This sleep apnea devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sleep apnea devices market consists of sales of automatic positive airway pressure, biPAP machines, autoPAP machines, positional therapy devices, and implant systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The sleep apnea devices market size is expected to see strong growth in the next few years. It will grow to $11.72 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to advancements in home sleep testing, personalized treatment approaches, increasing adoption of oral appliances, focus on pediatric sleep apnea, patient compliance improvement, emerging markets and increased access. Major trends in the forecast period include telemedicine and remote monitoring, portable and travel-friendly devices, integration of wearable technologies, customization and personalization of therapies, research in implantable devices.
The anticipated growth in the sleep apnea devices market is fueled by the escalating prevalence of sleep apnea disorders. Characterized by recurrent pauses and starts in breathing during sleep, sleep apnea poses potential health risks, making sleep apnea devices crucial for treatment and prevention of sleep disturbances. These devices operate by continuously delivering pressurized air through tubing into a sleep mask, preventing the collapse of the patient's airways. Notably, in April 2022, the American Medical Association (AMA) reported that in the United States alone, 30 million people suffered from sleep apnea. The prevalence of sleep apnea affects one in fifteen Americans, constituting 6.62 percent of the population, with around 30 percent reporting symptoms. Consequently, the rising prevalence of sleep apnea disorders is a key driver for the growth of the sleep apnea device market.
The surge in obesity rates is expected to further propel the expansion of the sleep apnea devices market. Obesity, a medical condition characterized by the excessive accumulation of body fat, poses a significant health threat and is closely linked to sleep apnea. The global increase in obesity rates contributes to the heightened prevalence of sleep apnea, necessitating effective equipment for its management. In March 2022, the World Health Organization (WHO) reported that approximately 1 billion people worldwide, including 650 million adults, 340 million teenagers, and 39 million children, were classified as obese. This number continues to grow, with an estimated 167 million adults and children expected to face health consequences due to overweight or obesity by 2025. Consequently, the upward trend in obesity rates is a driving factor for the sleep apnea device market.
Key companies in the sleep apnea devices market are concentrating on developing innovative devices, such as bi-level positive airway pressure (BiPAP) machines, to enhance patient comfort and improve treatment adherence. BiPAP is a type of non-invasive ventilation primarily used to treat sleep apnea and other respiratory conditions. It provides two levels of pressure: a higher pressure during inhalation (IPAP) to help keep the airway open and a lower pressure during exhalation (EPAP) to facilitate easier breathing out. For example, in February 2024, ResMed, a U.S.-based medical device company, introduced the AirCurve 11 series. This new range of bilevel positive airway pressure (PAP) devices is designed to improve sleep apnea treatment by enhancing patient comfort and encouraging compliance with therapy.
Major players in the sleep apnea devices market are embracing a strategic partnership approach to facilitate home-based sleep apnea detection. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefit. For instance, in May 2023, Signifier Medical Technologies LLC, a US-based medical technology company, announced a partnership with Sunrise, a Hong Kong-based healthcare technology company. This collaboration integrates Sunrise's AI solutions with Signifier Medical's eXciteOSA daytime sleep apnea therapy technologies, enhancing patient care through more efficient diagnosis and treatments. The joint offering includes personalized home sleep testing and a patient management portal, empowering healthcare professionals to gather comprehensive information on patients' daily clinical experiences and optimize outcomes.
In July 2024, EnsoData, a U.S.-based software company, acquired sleep testing diagnostic technology from Resonea for an undisclosed sum. This acquisition is intended to significantly enhance EnsoData's capabilities in screening and diagnosing sleep apnea. The focus of this acquisition is to reduce costs and improve access to systematic screening for sleep apnea. Resonea is a company based in Arizona that specializes in sleep diagnostics.
Major companies operating in the sleep apnea devices market include ResMed Inc., Fisher And Paykel Healthcare Corporation Limited, Natus Medical Incorporated, Compumedics Limited, Somnoware Healthcare Systems Inc., DeVilbiss Healthcare LLC, Braebon Medical Corporation, Koninklijke Philips N.V., BMC Medical Co. Ltd., Lowenstein Medical Technology GmbH Co. KG, Nihon Kohden Corporation, Invacare Corporation, Cadwell Industries Inc., Oventus Medical Ltd., Inspire Medical Systems Inc., Itamar Medical Ltd., APEX Medical Corp., Drive DeVilbiss Healthcare, 3B Medical Inc., Airing LLC, Airway Management Inc., Bleep LLC, Circadiance LLC, GE Healthcare, HOFFRICHTER GmbH, Human Design Medical LLC, ImThera Medical Inc., Provent Sleep Therapy LLC, Resonea Inc., Sleepnet Corporation.
North America was the largest region in the sleep apnea devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global sleep apnea devices market during the forecast period. The regions covered in the sleep apnea devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sleep apnea devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Sleep apnea devices encompass a range of advanced equipment, notably Continuous Positive Airway Pressure (CPAP) machines, designed to mitigate snoring and prevent sleep apnea. These CPAP devices precisely administer optimal air pressure to a mask, ensuring the maintenance of open upper airway passages.
Key categories within the sleep apnea devices market include airway clearance systems, adaptive servo-ventilation (ASV), positive airway pressure (PAP) devices, oral appliances, oxygen devices, sleep screening devices, actuation systems, polysomnography (PSG) devices, and respiratory polygraphs. Airway-clearing systems, a vital component, aid in the expulsion of thick mucus, facilitating coughing or huffing to clear the lungs. This technology is instrumental in addressing conditions such as obstructive sleep apnea syndrome, central sleep apnea syndrome, and complex sleep apnea syndrome. Targeting diverse age demographics, including pediatric, adult, and geriatric populations, these devices find application across various healthcare settings, such as hospitals, clinics, diagnostic centers, ambulatory care centers, specialty care centers, and home healthcare.
The sleep apnea devices market research report is one of a series of new reports that provides sleep apnea devices market statistics, including sleep apnea devices industry global market size, regional shares, competitors with a sleep apnea devices market share, detailed sleep apnea devices market segments, market trends and opportunities, and any further data you may need to thrive in the sleep apnea devices industry. This sleep apnea devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sleep apnea devices market consists of sales of automatic positive airway pressure, biPAP machines, autoPAP machines, positional therapy devices, and implant systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Sleep Apnea Devices Market Characteristics3. Sleep Apnea Devices Market Trends and Strategies4. Sleep Apnea Devices Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Sleep Apnea Devices Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Sleep Apnea Devices Market34. Recent Developments in the Sleep Apnea Devices Market
5. Global Sleep Apnea Devices Growth Analysis and Strategic Analysis Framework
6. Sleep Apnea Devices Market Segmentation
7. Sleep Apnea Devices Market Regional and Country Analysis
8. Asia-Pacific Sleep Apnea Devices Market
9. China Sleep Apnea Devices Market
10. India Sleep Apnea Devices Market
11. Japan Sleep Apnea Devices Market
12. Australia Sleep Apnea Devices Market
13. Indonesia Sleep Apnea Devices Market
14. South Korea Sleep Apnea Devices Market
15. Western Europe Sleep Apnea Devices Market
16. UK Sleep Apnea Devices Market
17. Germany Sleep Apnea Devices Market
18. France Sleep Apnea Devices Market
19. Italy Sleep Apnea Devices Market
20. Spain Sleep Apnea Devices Market
21. Eastern Europe Sleep Apnea Devices Market
22. Russia Sleep Apnea Devices Market
23. North America Sleep Apnea Devices Market
24. USA Sleep Apnea Devices Market
25. Canada Sleep Apnea Devices Market
26. South America Sleep Apnea Devices Market
27. Brazil Sleep Apnea Devices Market
28. Middle East Sleep Apnea Devices Market
29. Africa Sleep Apnea Devices Market
30. Sleep Apnea Devices Market Competitive Landscape and Company Profiles
31. Sleep Apnea Devices Market Other Major and Innovative Companies
35. Sleep Apnea Devices Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Sleep Apnea Devices Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on sleep apnea devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for sleep apnea devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sleep apnea devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product Type: Airway Clearance System; Adaptive Servo-Ventilation (ASV); Positive Airway Pressure (PAP) Devices; Oral Appliances; Oxygen Devices; Sleep Screening Devices; Actigraphy Systems; Polysomnography (PSG) Device; Respiratory Polygraph2) By Patient Type: Pediatric; Adult; Geriatric
3) By Disease: Obstructive Sleep Apnea Syndrome; Central Sleep Apnea Syndrome; Complex Sleep Apnea Syndrome
4) By End User: Hospital and Clinics; Diagnostic Centers; Ambulatory Care Centers; Specialty Care Center; Home Healthcare
Subsegments:
1) By Airway Clearance System: High-Frequency Chest Wall Oscillation (HFCWO) Devices; Positive Expiratory Pressure (PEP) Devices; Mechanical Insufflation-Exsufflation Devices2) By Adaptive Servo-Ventilation (ASV): Automatic Pressure Adjustment Devices; Device With Variable Pressure Support
3) By Positive Airway Pressure (PAP) Devices: Continuous Positive Airway Pressure (CPAP) Machines; Bi-Level Positive Airway Pressure (BiPAP) Machines
4) By Oral Appliances: Mandibular Advancement Devices (MADs); Tongue-Retaining Devices (TRDs)
5) By Oxygen Devices: Oxygen Concentrators; Portable Oxygen Cylinders
6) By Sleep Screening Devices: Home Sleep Apnea Testing Devices; Screening Questionnaires
7) By Actigraphy Systems: Wearable Sleep Trackers; Non-Wearable Actigraphy Devices
Key Companies Mentioned: ResMed Inc.; Fisher and Paykel Healthcare Corporation Limited; Natus Medical Incorporated; Compumedics Limited; Somnoware Healthcare Systems Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- ResMed Inc.
- Fisher And Paykel Healthcare Corporation Limited
- Natus Medical Incorporated
- Compumedics Limited
- Somnoware Healthcare Systems Inc.
- DeVilbiss Healthcare LLC
- Braebon Medical Corporation
- Koninklijke Philips N.V.
- BMC Medical Co. Ltd.
- Lowenstein Medical Technology GmbH Co. KG
- Nihon Kohden Corporation
- Invacare Corporation
- Cadwell Industries Inc.
- Oventus Medical Ltd.
- Inspire Medical Systems Inc.
- Itamar Medical Ltd.
- APEX Medical Corp.
- Drive DeVilbiss Healthcare
- 3B Medical Inc.
- Airing LLC
- Airway Management Inc.
- Bleep LLC
- Circadiance LLC
- GE Healthcare
- HOFFRICHTER GmbH
- Human Design Medical LLC
- ImThera Medical Inc.
- Provent Sleep Therapy LLC
- Resonea Inc.
- Sleepnet Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 8.43 Billion |
| Forecasted Market Value ( USD | $ 11.72 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |
